STOCK TITAN

SOPH (SOPH) insider plans Rule 144 sale of common stock and discloses recent 10b5-1 trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An affiliate of SOPH has filed a Rule 144 notice to sell 380 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/20/2026. The filing lists an aggregate market value of $2,071.00 for this planned sale and shows that the shares were acquired as restricted stock units from the issuer on 01/18/2026.

The notice also details prior sales under a Rule 10b5‑1 trading plan for Manuela Valente over the past three months, including 636 shares sold on 01/06/2026 for $3,015.72, 2,085 shares sold on 01/05/2026 for $9,603.93, 381 shares sold on 12/19/2025 for $1,764.45, and 381 shares sold on 11/19/2025 for $1,530.86.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many SOPH shares are planned to be sold under this Rule 144 filing?

The Rule 144 notice states that 380 shares of common stock are planned to be sold, with an aggregate market value of $2,071.00.

When and where are the SOPH shares expected to be sold?

The filing lists an approximate date of sale of 01/20/2026, with the shares to be sold on the NASDAQ market.

Which broker is handling the planned SOPH Rule 144 stock sale?

The planned sale of 380 SOPH common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

How were the SOPH shares to be sold acquired by the seller?

The filing indicates the 380 common shares were acquired on 01/18/2026 as restricted stock units from the issuer, with the same date listed as the payment date and the nature of payment marked as N/A.

What SOPH shares has the seller already sold in the past three months?

Under a Rule 10b5‑1 plan for Manuela Valente, the notice lists several recent sales of SOPH common stock: 636 shares sold on 01/06/2026 for $3,015.72, 2,085 shares sold on 01/05/2026 for $9,603.93, 381 shares sold on 12/19/2025 for $1,764.45, and 381 shares sold on 11/19/2025 for $1,530.86.

What type of securities are covered by this SOPH Rule 144 notice?

The Rule 144 notice covers common stock of the issuer, with 67,847,058 shares outstanding noted in the securities information section.

Sophia Genetics Sa

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

354.16M
63.48M
6.46%
48.2%
0.06%
Health Information Services
Healthcare
Link
Switzerland
Rolle